Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Evaluating traditional loans versus credit builder options helps you determine the best path for credit growth based on your situation.
25,423 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Structure Therapeutics stock has surged after a major hedge fund increased its stake. This article breaks down what s...
A solid move by a seasoned fund—Alpine Capital Research increases its Arrow Electronics position. Learn what this cou...
On Mar. 5, oil surged and AI export worries weighed on tech names, sending the S&P 500, Nasdaq, and Dow lower. This a...
Translucent closed a $27 million Series A to expand its AI-native healthcare finance platform, targeting improved rev...
When a venerable logistics giant trades near the $120 mark, investors debate more than price. This guide weighs the u...
Insider trades can hint at a company's future, but not every move is meaningful. This article shows how to filter sig...
Bitmine Immersion Technologies moves toward a 5% ETH stake, threatening to redefine Ethereum's staking economics whil...
Dogecoin slides toward the $0.09 mark as on-chain activity shows holders scooping up DOGE while institutional flows s...
A federal court has blocked a tariff backup plan tied to a 10% global levy. This ruling highlights how policy changes...
Amentum faces a pivotal Q2 2026 earnings season. This deep dive breaks down backlog, margins, and guidance, with prac...
A new Northwestern Mutual study finds half of Americans fear their retirement savings won't last, with many taking no...